Viewing Study NCT00555906


Ignite Creation Date: 2025-12-26 @ 4:03 PM
Ignite Modification Date: 2025-12-30 @ 4:07 PM
Study NCT ID: NCT00555906
Status: COMPLETED
Last Update Posted: 2015-03-19
First Post: 2007-11-08
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: An Investigational Drug, Palbociclib (PD-0332991), Is Being Studied In Combination With Velcade And Dexamethasone In Patients With Multiple Myeloma. Patients Must Have Received Prior Treatment For Multiple Myeloma.
Sponsor: Pfizer
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2008-01
Start Date Type: None
Primary Completion Date: 2012-08
Primary Completion Date Type: ACTUAL
Completion Date: 2013-03
Completion Date Type: ACTUAL
First Submit Date: 2007-11-08
First Submit QC Date: None
Study First Post Date: 2007-11-09
Study First Post Date Type: ESTIMATED
Results First Submit Date: 2015-03-04
Results First Submit QC Date: None
Results First Post Date: 2015-03-19
Results First Post Date Type: ESTIMATED
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: 2013-09-18
Disp First Post Date Type: ESTIMATED
Last Update Submit Date: 2015-03-04
Last Update Post Date: 2015-03-19
Last Update Post Date Type: ESTIMATED